NTL HEALTHCARE has launched CerviCARE® AI AT, an on-premises version of its artificial intelligence-powered cervical screening platform, giving healthcare institutions an alternative to cloud-based deployment. The system analyzes cervical images to support clinical decision-making and can run on local PCs without dedicated servers or cloud infrastructure. The launch addresses a growing consideration in medical AI adoption: how healthcare providers manage sensitive patient data while integrating AI into existing IT environments.
NTL Healthcare Adds Local Deployment Option for Cervical Screening AI
NTL HEALTHCARE is expanding its women’s health technology portfolio with CerviCARE® AI AT, an on-premises version of its AI-powered cervical screening system. The new offering allows healthcare institutions to run image analysis and manage related data within their own IT environments rather than relying on a software-as-a-service (SaaS) deployment.
The launch reflects a broader consideration in healthcare AI adoption: institutions must evaluate not only what an AI system can do, but also where it runs, how patient information is handled and whether the deployment model fits existing security and infrastructure policies.
On-Premises AI Brings Data Management Under Local Control
CerviCARE® AI analyzes cervical images to support healthcare professionals in making clinical decisions during cervical screening. The new AI AT version retains the core analysis capabilities of the existing platform while introducing local installation.
According to NTL HEALTHCARE, CerviCARE® AI AT can be installed on local PCs without requiring a dedicated server or cloud infrastructure. This architecture gives healthcare providers another way to deploy medical AI, particularly where internal IT policies restrict external data transfers or where cloud connectivity is limited.
Keeping image processing and related data management within an institution’s IT environment can reduce the need to transmit sensitive medical information to external systems. It can also give internal IT teams greater control over storage, access permissions and data-handling practices.
However, on-premises deployment does not automatically guarantee privacy or security. Institutions remain responsible for endpoint protection, access controls, software updates, backups, audit logs and other safeguards. The actual level of protection depends on how the system is configured and maintained.
For healthcare organizations evaluating AI tools, this distinction is important. Deployment architecture is one part of a broader assessment that includes clinical suitability, cybersecurity, regulatory requirements and operational support.
DICOM Support Connects AI With Medical Imaging Workflows
CerviCARE® AI AT introduces DICOM file generation, allowing cervical images and associated information to be converted into the Digital Imaging and Communications in Medicine format.
DICOM is a widely used standard for storing, exchanging and managing medical imaging information. Support for the format can help healthcare institutions incorporate imaging data into established medical imaging workflows, depending on compatibility with their existing systems.
The addition may be relevant to providers seeking to manage AI-generated or AI-processed information alongside other clinical imaging records. Standardized formats can reduce friction when handling imaging data across compatible systems, although DICOM file generation alone does not establish seamless integration with every picture archiving and communication system (PACS), electronic health record or hospital information system.
NTL HEALTHCARE has not detailed specific third-party integrations, hardware requirements beyond local PC installation, or comparative performance results in the announcement. Healthcare buyers will therefore need to assess compatibility and deployment requirements before implementation.
SaaS and Local Installation Address Different IT Needs
With CerviCARE® AI AT, NTL HEALTHCARE now offers two deployment options: the existing SaaS version and the new on-premises edition.
A cloud-based model can reduce the need for local infrastructure management and may simplify software delivery and maintenance. An on-premises model, by contrast, can provide more direct institutional control over where data is processed and stored, while placing more responsibility for local IT operations on the healthcare provider.
Neither approach is universally preferable. The appropriate choice depends on an institution’s technical resources, connectivity, security requirements, procurement policies and applicable regulations.
The distinction is especially relevant across international healthcare markets, where hospitals and clinics operate under different data-protection frameworks and infrastructure constraints. A local deployment option can broaden the range of institutions able to evaluate a medical AI platform, but it does not by itself demonstrate compliance with any particular jurisdiction’s rules.
The company has positioned the new version as an extension of the existing platform rather than a replacement for its SaaS offering. Tae-hee Kim, CEO of NTL HEALTHCARE, said the release responds to healthcare institutions’ growing interest in how medical data is processed and managed within their own IT environments.
Clinical Validation and Governance Remain Essential
AI-assisted cervical screening sits within a clinically sensitive area of healthcare. While image-analysis tools may support clinical workflows, the announcement does not provide new sensitivity or specificity figures, prospective clinical trial results, or evidence that the on-premises version improves screening outcomes compared with the SaaS edition.
Healthcare providers should distinguish between the availability of an AI feature and evidence of its clinical performance. They also need to understand the system’s intended use, applicable regulatory status, validation in relevant patient populations and role in the clinician’s decision-making process.
The World Health Organization’s cervical cancer guidance emphasizes evidence-based screening and follow-up as part of comprehensive prevention and care. AI tools must fit into that wider clinical pathway rather than being evaluated solely on their technical architecture.
For NTL HEALTHCARE, offering both SaaS and on-premises deployment broadens the platform’s implementation choices. The next test will be whether the flexibility translates into successful adoption across varied clinical environments, supported by clear evidence of performance, secure data management and practical integration with existing workflows.
Market Landscape
Healthcare AI providers are increasingly addressing deployment flexibility alongside model capabilities. Cloud platforms can simplify centralized delivery, while on-premises systems appeal to institutions that want direct control over infrastructure and sensitive data.
Medical imaging standards such as DICOM help support the management and exchange of imaging information, but interoperability depends on implementation and compatibility with existing clinical systems.
NTL HEALTHCARE’s launch places CerviCARE® AI AT within this shift toward deployment choices tailored to institutional requirements. Its commercial opportunity will depend on clinical validation, regulatory suitability, cybersecurity, integration and the ability to support healthcare providers throughout implementation and maintenance.
Top Insights
- NTL HEALTHCARE has launched an on-premises version of its cervical screening AI, allowing healthcare institutions to process data within their own IT environments.
- CerviCARE® AI AT runs on local PCs without dedicated servers or cloud infrastructure, offering an alternative to the platform’s existing SaaS deployment.
- New DICOM file generation supports standardized medical imaging data management, although compatibility with individual hospital systems requires further verification.
- On-premises deployment can reduce external data transfers but still requires robust cybersecurity, access controls, maintenance and institutional governance.
- The platform’s clinical value will depend on validated performance, regulatory suitability and integration into existing cervical screening workflows.
Power Tomorrow’s Intelligence — Build It with TechEdgeAI
